Investing.com - Experian's (LON:EXPN) outlook for margin expansion is "robust" and underpins the potential for sustained ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...

Morgan Stanley likes financials, energy, real estate, and domestically-focused materials and consumer-goods companies.

The holiday period was the last time for Wall Street financiers to catch a breath before Donald Trump is handed the keys to ...

On the daily chart, the Nifty formed a red candle but respected the demand zone of 23,460–23,500, settling near the 200-day ...